Clinical trial

Islet Function in Gestational Diabetes

NCT07806695

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-09-01

PhasePHASE1

Study timeline

Study start (estimated)2026-09-01Date precision: month

Registry last updated2026-09-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Gestational Diabetes Mellitusunresolved

Interventions

Exendin 9-39DRUG

Sponsors & collaborators

Mayo Cliniclead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Mapped research locations

RochesterMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07806695 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.